336134
Assessing How Surveys Assess Hearing in Participants: Impacts of connotations and approach onto results
The primary objectives were to evaluate how well surveillance questions assess hearing and to describe the surveillance data collection methods that may impact responses and participation by DHH eligible individuals. We assessed surveys and administrative data definitions (National Health and Nutritional Examination Surveys, the American Community Survey, state Behavioral Risk Factor Surveys, and targeted surveys (Barnett et al., 2011), and ICD codes) to identify how hearing loss is assessed and how this may influence how individuals respond or are included. We also evaluated the engagement approaches.
These findings will be reported in formats that engage different DHH groups into the development of hearing loss survey questions and considerations of how to maximize participation of these individuals into surveillance. Standardization of the hearing questions could help improve surveillance of the DHH population.
Learning Areas:
Advocacy for health and health educationDiversity and culture
Epidemiology
Other professions or practice related to public health
Planning of health education strategies, interventions, and programs
Public health or related laws, regulations, standards, or guidelines
Learning Objectives:
Compare approaches in the determination of deaf and hard of hearing populations in public health data sets; Describe health disparities experienced by DHH populations; Identify DHH advocacy groups
Qualified on the content I am responsible for because: Ms. Russette has an MPH and seven years of experience in the area of disability and health. She is the recipient of the Gates Millennium Scholarship, the Pat Williams Scholarship from the Public Policy and Leadership Initiative of the UM Maureen and Mike Mansfield Center (2011-2012), and the APHA Disability Section Student Travel Scholarship (2012).
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.